Prophylactic Heart Failure Pharmacotherapy Is Safe and Effective in Patients With HER2-overexpressing Breast Cancer
Prophylactic use of standard HF pharmacotherapy appears to be effective for patients with HER2-overexpressing breast cancer.
Prophylactic use of standard HF pharmacotherapy appears to be effective for patients with HER2-overexpressing breast cancer.
Nipple-sparing mastectomy and immediate breast reconstruction results in higher reported patient body image, when compared to skin-sparing partial mastectomy (SS-PM), and may lower risk of local recurrence.